|
|
|
|
AG3340
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called angiogenesis inhibitors. AG3340 is a matrix metalloproteinase inhibitor. Also called prinomastat. (National Cancer Institute)
Pathogenesis of ventilator-induced lung injury: trials and ... Mar 8, 2005 Attenuation by the synthetic matrix metalloproteinase inhibitor, prinomastat (ag3340). Am J Respir Cell Mol Biol 25: 717–724, 2001. [Abstract/Free Full Text]. ... AJP-Lung Physiology
Resources from the National Cancer Institute on AG3340:
Angiogenesis Imaging Methodology: AIM for Clinical Trials File Format: PDF/Adobe Acrobat - View as HTML ... clinical trial. Examples of these agents include Marimastat, AG3340 (Prinomastat),
Col-3, Neovastat, and BMS275291. Page 9. Endothelial ...
|
|
|